In this InSight Studio interview, we speak with Dr. Art Epstein on Meibomian Gland Dysfunction, and why “Dry Eye” is an Antiquated term. He hits on some of the big issues in ocular surface disease today, including:
* Will meibography become a standard of care?
* The current crop of OSD treatments
* Whether meibomian gland clearance is necessary to treat the underlying condition
In this InSight Studio interview from Optometry’s Meeting 2019 in St. Louis, Dr. Ben Chudner sits down with us to discuss private equity in optometry.
He hits on:
* What private equity is
* The differences between private equity groups
* Where companies are looking to invest
* What makes a practice an attractive target for private equity
* Should your practice be acquired by private equity?
Leave any comments or questions for Dr. Chudner in this thread.
In this InSight Studio interview from SECO2019, we speak with Dr. Richard Madonna from SUNY Optometry, where he explains why hypertension is a risk factor for glaucoma. (surprisingly, the answer has part to do with hypotension!)
The FTC is proposing changes to the Contact Lens Rule that can impact both clinicians and patients alike.
In this InSight Studio interview, we speak with Edward S. Bennett, O.D., M.S.Ed., Chair of the Contact Lens and Cornea Section Council of the American Optometric Association about the proposed changes, and how docs can help prevent illegal contact lens sales.
Remember to report any illegal sales to the AOA via e-mail at StopIllegalCLs@aoa.org
